Vig Pamela 4
4 · Mirum Pharmaceuticals, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Vig Pamela
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-01-09$20.62/sh−1,379$28,438→ 27,312 total
Holdings
- 75,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.